[Federal Register Volume 61, Number 167 (Tuesday, August 27, 1996)]
[Rules and Regulations]
[Pages 43963-43964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-21848]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Part 520


Oral Dosage Form New Animal Drugs; Ivermectin Tablets and 
Chewable Cubes; Correction

AGENCY: Food and Drug Administration, HHS.


[[Page 43964]]


ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of July 31, 1996 (61 FR 
39867). The document amended the animal drug regulations to reflect 
approval of two supplemental new animal drug applications (NADA's) 
filed by Merck Research Laboratories, Division of Merck & Co., Inc. The 
document was published with a typographical error in the title. This 
document corrects that error.

EFFECTIVE DATE: July 31, 1996.

FOR FURTHER INFORMATION CONTACT: Marcia K. Larkins, Center for 
Veterinary Medicine (HFV-112), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-827-0137.
    In FR Doc. 96-19410, appearing on page 39867 in the Federal 
Register of Wednesday, July 31, 1996, the following correction is made: 
On page 39867, in the second column, the title of the document is 
corrected to read ``Oral Dosage Form New Animal Drugs; Ivermectin 
Tablets and Chewable Cubes.''

    Dated: August 19, 1996.
Robert C. Livingston,
Director, Office of New Animal Drug Evaluation,Center for Veterinary 
Medicine.
[FR Doc. 96-21848 Filed 8-26-96; 8:45 am]
BILLING CODE 4160-01-F